Teladoc Health Inc
TDOC
ISIN null / Valor 28438140
Teladoc Health Inc
UMushroom community rating:
About company
focus on providing virtual healthcare services through a network of U.S. board-certified healthcare professionals, including internists, family doctors, nurse practitioners, dermatologists, psychiatrists, and pediatricians. The company offers a wide range of medical specialties, allowing patients to receive diagnosis, treatment, and prescriptions for common non-emergency health issues via phone or video consultations. Additionally, Teladoc Health connects patients with global medical specialists for complex conditions, treatment plans, and surgeries. The company's services are accessible to individuals in the U.S. and Canada, with licensed physicians available in various provinces and states to provide personalized care from anywhere.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (08.10.2025):
Teladoc Health Inc reported its financial results for the second quarter of 2025, demonstrating a slight decline in revenue and adjusted EBITDA compared to the same period in the previous year. Despite these challenges, the company continues to enhance its financial and operational flexibility through strategic financial actions.
Revenue Decline
In the second quarter of 2025, Teladoc Health Inc achieved revenue of $631.9 million, marking a 2% decrease year-over-year from $642.4 million in the second quarter of 2024.
Net Loss Reduction
The company reported a net loss of $32.7 million, or $0.19 per share, for the second quarter of 2025, a significant improvement from a net loss of $837.7 million, or $4.92 per share, in the same quarter the previous year.
Adjusted EBITDA Drop
Adjusted EBITDA for the second quarter of 2025 was $69.3 million, reflecting a 23% decrease compared to $89.5 million in the second quarter of 2024.
Segment Performance
The Integrated Care segment saw a 4% increase in revenue to $391.5 million with an adjusted EBITDA margin of 14.7%, while the BetterHelp segment experienced a 9% decrease in revenue to $240.4 million and an adjusted EBITDA margin of 4.9%.
Financial Strategy Enhancements
Teladoc Health Inc utilized $550.6 million in cash to retire convertible senior notes due in the second quarter of 2025 and entered into a five-year, $300 million senior secured revolving credit facility on July 17, 2025, to bolster its financial and operational flexibility.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1194 M
Market cap (USD)
10,399,276
Daily traded volume (Shares)
9.34 / 8.97
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
